Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging

Bone Marrow Transplantation

Volumn 25, Issue 6, 2000, Pages 639-645

  Gautam, S C ^a   Xu, Y X ^a   Dumaguin, M ^a   Janakiraman, N ^a   Chapman, R A ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Bone marrow; Leukemia; Purging; Resveratrol

Indexed keywords

ANTILEUKEMIC AGENT; DNA FRAGMENT; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW PURGING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HEMATOPOIESIS; HUMAN; HUMAN CELL; IRRADIATION; LETHALITY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034103188     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702189     Document Type: Article

References (24)

1. Vesole DH, Jagannath S, Glenn L, Barlogie B. Auto transplantation in multiple myeloma. Hematol Oncol 1993; 7: 613-630.
2. Petersen FB, Lynch MHE, Clift RA et al. Autologous bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 1993; 11: 1353-1360.
3. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
4. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 85-86.
5. Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380-383.
6. Gribben JG, Arnold MD, Freedman AS et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
7. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636-640.
8. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia using ex vivo marrow treatment with 4-hydroxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
9. Jones RJ. Purging with 4-hydroperoxycyclophosphamide. J Hematother 1992; 1: 343-348.
10. Laporte JP, Douay L, Lopez M et al. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged with mafosamide: A 10 year single institution experience. Blood 1994; 84: 3810-3818.
11. Gulati SC, Acaba L, Yahalom J et al. Autologous bone marrow transplantation for acute myelogenous leukemia using 4 hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone Marrow Transplant 1992; 10: 129-137.
12. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
13. Belguendouz L, Fremont L, Gozzelino MT. Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol 1998; 15: 811-816.
14. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-1104.
15. Pace-Asciak CR, Hahn S, Diamandis EP et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart diseuse. Clin Chim Acta 1995; 235: 207-219.
16. Rotondo S, Rajtar G, Manarini S et al. Effects of transresveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998; 123: 1691-1699.
17. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985; 834: 275-278.
18. Belguendouz L, Fremont L, Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997; 53: 1347-1355.
19. Bertelli AA, Giovannini L, Bernini W et al. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 1996; 22: 61-63.
20. Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220.
21. Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998; 12: 865-869.
22. Jayatilake GS, Jayasuria H, Lee HS et al. Kinase inhibitors from poly gonum cuspidatum. J Nat Prod 1993; 56: 1805-1810.
23. Synold TW, Doroshow TW. Resveratrol, a phenolic constituent of wine inhibits topoisomerase II and induces apoptosis in human leukemia cells. Proc Am Assoc Cancer Res 1998; 39: 422 (Abstr.).
24. Clement MV, Hirapa JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92: 996-1002.